Italian Prime Minister Giorgia Meloni denies discussing a deal with Elon Musk's Starlink for encrypted telecommunications ...

Nu Skin could benefit from potential tax reductions under the new U.S. administration, which may increase net income and ...

Vir Biotechnology's recent share price rally is driven by their promising cancer program. Having shot to over a $1.5B market ...

JPMorgan Chase is expected to report Q4 earnings with a revenue increase of 7-9% and EPS growth of 33%. Click here to read my ...

ProAssurance faces challenges in medical malpractice insurance, but shows improvement in net income. See why I rate PRA stock as a Strong Buy.

Nurix Therapeutics (NRIX) leads in targeted protein modulation with its DELigase platform, developing BTK degraders like ...

Amazon’s satellite broadband initiative, Project Kuiper, shows huge potential. Find out why AMZN stock could thrive with a ...

Investors in fertilizer equities can expect steady prices and good cash generation, according to analysts at RBC Capital Markets.

Hims & Hers capitalizes on telehealth growth in hair, mental, sexual health, and weight loss. Yet, limited product ...

Financial writer recommends buying LifeVantage stock after exceeding Q2/FY2025 expectations with new MindBody GLP-1 System launch.

Tencent's strong fundamentals and buyback strategy present a buying opportunity despite U.S. blacklisting. Click here to read ...